Cargando…

Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing

In the UK, the Medicines and Healthcare products Regulatory Agency consulted on proposals “to improve and strengthen the UK clinical trials legislation to help us make the UK the best place to research and develop safe and innovative medicines”. The purpose of the consultation was to help finalise t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Law, Martin, Couturier, Dominique-Laurent, Choodari-Oskooei, Babak, Crout, Phillip, Gamble, Carrol, Jacko, Peter, Pallmann, Philip, Pilling, Mark, Robertson, David S., Robling, Michael, Sydes, Matthew R., Villar, Sofía S., Wason, James, Wheeler, Graham, Williamson, S. Faye, Yap, Christina, Jaki, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552399/ https://www.ncbi.nlm.nih.gov/pubmed/37798805 http://dx.doi.org/10.1186/s13063-023-07576-7

Ejemplares similares

Correction: Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing
por: Law, Martin, et al.
Publicado: (2023)

Adaptive designs in clinical trials: why use them, and how to run and report them
por: Pallmann, Philip, et al.
Publicado: (2018)

Point estimation for adaptive trial designs II: practical considerations and guidance
por: Robertson, David S., et al.
Publicado: (2023)

Point estimation for adaptive trial designs I: A methodological review
por: Robertson, David S., et al.
Publicado: (2022)

A Bayesian adaptive design for clinical trials in rare diseases
por: Williamson, S. Faye, et al.
Publicado: (2017)

Practical guidance for planning resources required to support publicly-funded adaptive clinical trials
por: Wason, James M. S., et al.
Publicado: (2022)

Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project
por: Wilson, Nina, et al.
Publicado: (2021)

Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs
por: Burnett, Thomas, et al.
Publicado: (2020)

Adding new experimental arms to randomised clinical trials: Impact on error rates
por: Choodari-Oskooei, Babak, et al.
Publicado: (2020)

Generalisations of a Bayesian decision-theoretic randomisation procedure and the impact of delayed responses
por: Williamson, S. Faye, et al.
Publicado: (2022)

Combined test versus logrank/Cox test in 50 randomised trials
por: Royston, Patrick, et al.
Publicado: (2019)

A third trial oversight committee: Functions, benefits and issues
por: Lane, J Athene, et al.
Publicado: (2019)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

Optimal design for multi-arm multi-stage clinical trials
por: Wason, James MS, et al.
Publicado: (2011)

Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit
por: Royston, Patrick, et al.
Publicado: (2011)

Prospective reporting of statistical analysis plans for randomised controlled trials
por: Hemming, Karla, et al.
Publicado: (2020)

An ethnographic study of group decision making to understand and improve how trial steering committees contribute to trial conduct
por: Daykin, Anne, et al.
Publicado: (2013)

Legislation and standards of the European Agency for Safety and Health at Work
por: European Agency for Safety and Health at Work. Bilbao
Publicado: (2000)

Proposals on Kaplan–Meier plots in medical research and a survey of stakeholder views: KMunicate
por: Morris, Tim P, et al.
Publicado: (2019)

Risk-adapted approaches to the management of clinical trials: guidance from the Department of Health (DH)/Medical Research Council(MRC)/Medicines and Healthcare Products Regulatory Agency (MHRA) Clinical Trials Working Group
por: Meredith, Sarah, et al.
Publicado: (2011)

Treatment selection in multi-arm multi-stage designs: With application to a postpartum haemorrhage trial
por: Choodari-Oskooei, Babak, et al.
Publicado: (2023)

Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes
por: Bratton, Daniel J., et al.
Publicado: (2016)

Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study
por: Jaki, Thomas, et al.
Publicado: (2018)

Some recommendations for multi-arm multi-stage trials
por: Wason, James, et al.
Publicado: (2012)

A cohort examination to establish reporting of the remit and function of Trial Steering Committees in randomised controlled trials
por: Conroy, Elizabeth J., et al.
Publicado: (2017)

A new measure of predictive ability for survival models
por: Choodari-Oskooei, Babak, et al.
Publicado: (2011)

Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework
por: Blenkinsop, Alexandra, et al.
Publicado: (2019)

Online error rate control for platform trials
por: Robertson, David S., et al.
Publicado: (2023)

The extension of total gain (TG) statistic in survival models: properties and applications
por: Choodari-Oskooei, Babak, et al.
Publicado: (2015)

What are the roles and valued attributes of a Trial Steering Committee? Ethnographic study of eight clinical trials facing challenges
por: Daykin, Anne, et al.
Publicado: (2016)

Designing and evaluating dose-escalation studies made easy: The MoDEsT web app
por: Pallmann, Philip, et al.
Publicado: (2019)

Evidence base for patient and public involvement in clinical trials (EPIC)
por: Gamble, Carrol, et al.
Publicado: (2013)

Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently
por: White, Ian R, et al.
Publicado: (2022)

Legislation for trial registration and data transparency
por: Bian, Zhao-Xiang, et al.
Publicado: (2010)

Statistical consideration when adding new arms to ongoing clinical trials: the potentials and the caveats
por: Lee, Kim May, et al.
Publicado: (2021)

Costs and consequences of the Family Nurse Partnership (FNP) programme in England: evidence from the Building Blocks trial
por: Bell, Kerry, et al.
Publicado: (2019)

Review and evaluation of performance measures for survival prediction models in external validation settings
por: Rahman, M. Shafiqur, et al.
Publicado: (2017)

A mapping and gapping analysis of patient and public involvement in a clinical trials unit
por: Bagley, Heather, et al.
Publicado: (2013)

Implementation of the Family Nurse Partnership programme in England: experiences of key health professionals explored through trial parallel process evaluation
por: Sanders, J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q1o2lv67lvt2j3qvg38i7keln5